Use access key #2 to skip to page content.
$10.43 -1.60 (-13.30%)
12/1/2008 4:00 PM

inVentiv Health, Inc. (VTIV)

CAPS Rating:
*****

The Company is a provider of value-added services to the pharmaceutical and life sciences industries.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating VTIV

Add Stock to Watchlist

What the Community Thinks

Total Members

1079 Outperforms
22 Underperforms
 

All-Stars

155 Outperforms
8 Underperforms
 

Wall Street

8 Outperforms
0 Underperforms
 

Members bullish on VTIV are also bullish on:

Members bearish on VTIV are also bearish on:

Ticker Tags

Healthcare Providers and Services (129), Micro Cap (4862)
Suggest a tag

inVentiv Health, Inc. At A Glance

Current Price: $10.43
Last Trade Time: 12/1/2008 4:00 PM
Open: $0.00
Previous Close: $12.03
Daily Range: $10.35 - $11.79
52-Week Range: $7.93 - $35.87
Volume: 257,692
Market Cap: $400.14M
P/E Ratio: 7.86
Compare Our Special Broker Offers!

Stock Trends

VTIV VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for VTIV

More Headlines...

Top Bull Pitch

Recs

2

inVentiv Health, Inc. (VTIV)

Avatar TMFDitty (98.60) Submitted: 8/17/08 11:49 PM

BOTEV on inVentiv: $69M FCF x 24% growth = $1.6B valuation. This one looks like a double to me. Add in the facts that (i) it has much of the upside from a growing medical industry, and little of the downside from regulation of Big Pharma, plus (ii) minimal capex, which I'm realizing is a big plus, a...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 115 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (VTIV)

Avatar DistressedCaps (95.62) Submitted: 11/18/08 7:39 PM : Outperform Start Price: $11.35 VTIV Score: -3.68

On 11/18/08, a 5 star stock that is down more than 60 % from its yearly high but recent momentum.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (VTIV)

Avatar TMFBiologyFool (98.04) Submitted: 11/07/08 1:08 PM : Outperform Start Price: $12.29 VTIV Score: -3.99

Should have grabbed it earlier in the month. Oh well. It still seems like a great deal at these prices.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (VTIV)

Avatar VIS46 (< 20) Submitted: 10/17/08 8:19 PM : Outperform Start Price: $11.25 VTIV Score: 6.68

drug marketing outsourcing is here to stay and big pharma could concentrate on reserch.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (VTIV)

Avatar wolfhounds (64.75) Submitted: 10/16/08 10:09 AM : Outperform Start Price: $11.01 VTIV Score: 3.31

This stock is priced as if at least half it's future business has permanently disappeared. The mantra of the drug and biotech industries in recent years has been the necessity to reduce costs by outsourcing. At a current p/e of less than 7, it is highly likely increased business in future years could make this one of the great buys in this feraful market.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (VTIV)

Avatar JP1031 (66.81) Submitted: 10/10/08 4:09 PM : Outperform Start Price: $12.25 VTIV Score: -1.77

Good financials in a growing industry offering services to providers with a lot of money. This seems to be a safe bet.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 115 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 8 of 8  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackCarisandCo 21.74 11/07/08 Outperform NS $12.36-15.61%-11.71%-3.91
TrackRonBaron < 20 03/31/08 Outperform NS $28.81-63.80%-37.78%-26.02 Toggle the visibility of 60-Second Pitch and replies
TrackBroadpointC < 20 11/08/07 Outperform NS $34.40-69.68%-44.52%-25.16
TrackSoros < 20 09/30/07 Outperform NS $43.82-76.20%-46.19%-30.01 Toggle the visibility of 60-Second Pitch and replies
TrackJefferies < 20 07/27/07 Outperform NS $36.77-71.63%-44.60%-27.04
TrackBofASec 94.34 02/07/07 Outperform NS $36.69-71.57%-43.42%-28.15
TrackLehmanBros < 20 12/28/06 Outperform NS $34.78-70.01%-42.34%-27.67
TrackFirstAlbany < 20 11/29/06 Outperform NS $30.74-66.07%-41.16%-24.91

Results 1 - 8 of 8  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links